HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenta Kurayoshi Selected Research

E2F Transcription Factors

1/2018Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes.
1/2017The phosphatidyl inositol 3 kinase pathway does not suppress activation of the ARF and BIM genes by deregulated E2F1 activity.
9/2015Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts.
7/2014Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenta Kurayoshi Research Topics

Disease

6Neoplasms (Cancer)
08/2022 - 07/2014
1Central Nervous System Diseases (CNS Diseases)
08/2022
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2022

Drug/Important Bio-Agent (IBA)

4E2F Transcription FactorsIBA
01/2018 - 07/2014
1Amoxapine (Asendin)FDA Link
08/2022
1Pharmaceutical PreparationsIBA
08/2022
1ifenprodilIBA
08/2022
1NucleotidesIBA
01/2022

Therapy/Procedure

3Therapeutics
08/2022 - 01/2017
1Oncolytic Virotherapy
07/2014